// App-Quantinova.ai

: Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis

Researchers

Presenter

  • Mary Mcelroy

Principal Investigators

  • James Baily

  • Oriol Peris Serrano

  • Angela Marsden

  • Mike Briggs

  • Iain Love

  • Stephen Madden

  • Senthil Gandi

  • Mark Whitmarsh

  • Alan Young

Medical Centers

  • MRC, Edinburgh, United Kingdom

  • CRL, Harlow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nintedanib

  • Bleomycin

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved